Comparison of Two Novel Anti Diabetes Medications Classes as Regard Prostate Symptoms in Patient With Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus
- Sponsor
- Kasr El Aini Hospital
- Enrollment
- 57
- Locations
- 2
- Primary Endpoint
- Change in prostate symptoms
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus
Detailed Description
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus The study compares sodium glucose cotransporter 2 inhibitors to Dipeptidyl peptidase 4 inhibitors in elderly patients with type 2 diabetes mellitus
Investigators
Tarek Samy Abdelaziz
Associate professor of Internal medicine and nephrology
Kasr El Aini Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients with diabetes and benign prostatic hyperplasia should be on monotherapy with either SGLT inhibitor or DDP4 inhibitors
Exclusion Criteria
- •unable to consent to the blood sampling or ultrasound Any other diabetes control measure other than SGLT inhibitors or DDP 4 inhibitors
Outcomes
Primary Outcomes
Change in prostate symptoms
Time Frame: one year
As indicated by change in the International prostate score system
change in prostate volume
Time Frame: one year
The delta change in prostate volume as measured by Ultrasound